Ligand, American Home Products deal

Under the 1994 agreement, the companies are developing drugs that interact with estrogen or progesterone receptors for use in hormone replacement therapy, cancer, gynecological diseases, contraception, and central nervous system disorders associated with menopause, in addition to osteoporosis. ...